Clinical and pharmacokinetic study of gemcitabine (GEM) - oxaliplatin (OXA) association in metastatic or locally advanced pancreatic adenocarcinoma.

被引：0
作者：
Airoldi, M
Cattel, L
Passera, R
Micari, C
Ferrarato, E
Zanon, C
机构：
[1] Osped San Giovanni Ant Sede, Turin, Italy
[2] Univ Turin, Fac Farm, Turin, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2059
引用
收藏
页码：141S / 141S
页数：1
相关论文
共 50 条
[41]   Safety and efficacy of gemcitabine/nabpaclitaxel in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: a retrospective analysis [J].
Ventriglia, J. ;
Laterza, M. M. ;
Savastano, B. ;
Petrillo, A. ;
Tirino, G. ;
Pompella, L. ;
Pappalardo, A. ;
Orditura, M. ;
Ciardiello, F. ;
De Vita, F. .
ANNALS OF ONCOLOGY, 2017, 28
[42]   NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer [J].
Sahora, Klaus ;
Kuehrer, Irene ;
Eisenhut, Axel ;
Akan, Belgin ;
Koellblinger, Claus ;
Goetzinger, Peter ;
Teleky, Bela ;
Jakesz, Raimund ;
Peck-Radosavljevic, Markus ;
Ba'ssalamah, Ahmed ;
Zielinski, Christoph ;
Gnant, Michael .
SURGERY, 2011, 149 (03) :311-320
[43]   Locally Advanced or Metastatic Pancreatic Adenocarcinoma: Easily Available Factors of Predictive Prolonged Survival Under Gemcitabine [J].
Ploquin, Anne ;
Truant, Stephanie ;
Piessen, Guillaume ;
Vuagnat, Perrine ;
Baldini, Capucine ;
Cattan, Stephane ;
Hebbar, Mohamed .
IN VIVO, 2017, 31 (04) :731-735
[44]   Immunotherapy engagement in pancreatic adenocarcinoma: Provisional results of iLSTA study- Durvalumab, LSTA1 (certepetide), gemcitabine, and nab-paclitaxel for locally advanced pancreatic ductal adenocarcinoma. [J].
Dean, Andrew Peter ;
Johansson, Mikael ;
Yusoff, Ian ;
Rao, Samarth ;
Sparrow, Susan ;
Kumarasinghe, Priyanthi ;
Navadgi, Suresh ;
Watanabe, Yuki ;
Webber, Laurence ;
Grew, Jenny ;
Fitzgerald, Shane ;
Comito, Olivia Rose .
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL)
[45]   Biologically optimized schedule of gemcitabine and nab-paclitaxel regimen in metastatic pancreatic adenocarcinoma. [J].
Abushahin, Laith I. ;
Noonan, Anne M. ;
Hays, John L. ;
Malalur, Pannaga G. ;
Manne, Ashish ;
Jin, Ning ;
Mittra, Arjun ;
Elkhatib, Rifat T. ;
Roychowdhury, Sameek ;
Williams, Terence Marques .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[46]   Gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer: a prospective observational study [J].
Karasek, P ;
Skacel, T ;
Kocakova, I ;
Bednarik, O ;
Petruzelka, L ;
Melichar, B ;
Bustova, I ;
Spurny, V ;
Trason, T .
EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (04) :581-586
[47]   Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study [J].
Alberts, SR ;
Townley, PM ;
Goldberg, RM ;
Cha, SS ;
Sargent, DJ ;
Moore, DF ;
Krook, JE ;
Pitot, HC ;
Fitch, TR ;
Wiesenfeld, M ;
Mailliard, JA .
ANNALS OF ONCOLOGY, 2003, 14 (04) :580-585
[48]   A phase II study of preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with locally advanced rectal adenocarcinoma. [J].
Duck, LR ;
Sempoux, C ;
Honhon, B ;
Coster, B ;
Coche, JC ;
Kerger, J ;
Canon, JL ;
Humblet, Y ;
Scalliet, P ;
Machiels, JP .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :258S-258S
[49]   Combination therapy with gemcitabine and Atu027 in patients with locally advanced or metastatic pancreatic adenocarcinoma - a Phase Ib/IIa study [J].
Schultheis, B. ;
Strumberg, D. ;
Kuhlmann, J. ;
Wolf, M. ;
Link, K. ;
Seufferlein, T. ;
Kaufmann, J. ;
Gebhardt, F. ;
Khan, M. ;
Pelzer, U. .
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 :64-64
[50]   A phase 1/2 study of combination therapy of ivaltinostat, gemcitabine, and erlotinib in patients with unresectable, locally advanced and metastatic pancreatic adenocarcinoma [J].
Jo, J. ;
Lee, H. ;
Park, S. ;
Chung, D. ;
Cho, S. ;
Cha, H. ;
Cho, J. ;
Song, S. .
ANNALS OF ONCOLOGY, 2020, 31 :S211-S211
12345